News

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs

Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to the right patient at the right time.

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.

Oils from garlic and several other common herbs and medicinal plants show strong activity against the bacterium that causes Lyme disease.

An innovative approach has been used to identify thousands of antibiotic resistance genes found in bacteria that inhabit the human gut.

A two-year assessment demonstrates that durable remissions can be achieved in a substantial proportion of patients with an acceptable long-term safety profile.

Increased PD-L1 expression in the muscles of myasthenia gravis patients has been linked with disease severity and shown that this could ultimately help control the immune response and modulate disease symptoms.

The goal isn’t to make artificial organs that can be implanted in the body, but to make easy-to-grow human organ models that can be studied outside the body or used for pharmaceutical drug screening.

Curcumin, a main ingredient in curry, may improve exercise intolerance related to heart failure.

Researchers utilize a steady-state/lifetime fluorescence-based, high-throughput platform to develop a general workflow for direct formulation optimization under analytically challenging but commercially relevant conditions.